Categories: Market Research

Global Acute Ischemic Stroke Diagnosis Market Size and Forecast 2024-2033|Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC

The Acute Ischemic Stroke Diagnosis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Acute Ischemic Stroke Diagnosis Market:

https://www.thebusinessresearchcompany.com/report/acute-ischemic-stroke-diagnosis-global-market-report

According to The Business Research Company’s Acute Ischemic Stroke Diagnosis Global Market Report 2024, The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.14 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in cardiovascular risk factors, telemedicine adoption, establishment of stroke centers, increased aging population, development of thrombolytic therapies.

The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to remote monitoring technologies, patient-centric healthcare models, integration of wearable devices, point-of-care testing devices, expansion of mobile stroke units. Major trends in the forecast period include advancements in imaging technologies, advancements in artificial intelligence, genetic and biomarker product innovations, blockchain for data security, integration of augmented reality.

The rising prevalence of acute ischemic stroke cases is expected to propel the growth of the acute ischemic stroke diagnosis market going forward. Acute ischemic stroke refers to a severe medical emergency brought on by poor blood supply to the brain, which causes brain cell destruction. Early diagnosis of acute ischemic stroke will aid in treatment and reduce brain damage and other consequences resulting from the stroke. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, stroke deaths increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. Further, in the United States, there are more than 795,000 strokes per year; 610,000 are first-time strokes and ischemic strokes, in which blood flow to the brain is impeded, account for around 87% of all strokes. Therefore, the rising prevalence of acute ischemic stroke cases is driving the growth of the acute ischemic stroke diagnosis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12150&type=smp

The acute ischemic stroke diagnosis market covered in this report is segmented –

1) By Diagnostic Type: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics

2) By Surgery Type: Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy

3) By Application: Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive

Product innovations are a key trend gaining popularity in the acute ischemic stroke diagnosis market. Major companies operating in the acute ischemic stroke diagnosis market are innovating new products to maintain their position in the market. For instance, in February 2022, Imperative Care Inc., a US-based medical equipment manufacturing company, launched Zoom POD Aspiration Tubing, the latest advancement in improving stroke therapy. The Zoom POD is the first and only sterile field clot filter device, allowing patients with ischemic stroke to undergo crucial mechanical thrombectomy procedures more quickly. The Zoom POD is integrated into the aspiration tube, reducing the distance from aspiration to filtration while preserving full aspiration strength. The Zoom POD streamlines and expedites a crucial step of the treatment by giving the doctor a quick view and confirming the effective removal of the clot.

The acute ischemic stroke diagnosis market report table of contents includes:

1. Executive Summary

2. Acute Ischemic Stroke Diagnosis Market Characteristics

3. Acute Ischemic Stroke Diagnosis Market Trends And Strategies

4. Acute Ischemic Stroke Diagnosis Market – Macro Economic Scenario

5. Global Acute Ischemic Stroke Diagnosis Market Size and Growth

26. South America Acute Ischemic Stroke Diagnosis Market

27. Brazil Acute Ischemic Stroke Diagnosis Market

28. Middle East Acute Ischemic Stroke Diagnosis Market

29. Africa Acute Ischemic Stroke Diagnosis Market

30. Acute Ischemic Stroke Diagnosis Market Competitive Landscape And Company Profiles

Top Major Players: